Chaperonin (HSP60) and annexin-2 are candidate biomarkers for non-small cell lung carcinoma

BACKGROUND: Lung cancer is responsible of 12.4% and 17.6% of all newly diagnosed cancer cases and mortality due to cancer, respectively, and 5-year survival rate despite all improved treatment options is 15%. This survival rate reaches 66% in the Stage 1 and surgically treated patients. Early diagno...

Descripción completa

Detalles Bibliográficos
Autores principales: Ağababaoğlu, İsmail, Önen, Ahmet, Demir, Ayşe Banu, Aktaş, Safiye, Altun, Zekiye, Ersöz, Hasan, Şanlı, Aydın, Özdemir, Nezih, Akkoçlu, Atila
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312986/
https://www.ncbi.nlm.nih.gov/pubmed/28178129
http://dx.doi.org/10.1097/MD.0000000000005903

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312986/
https://www.ncbi.nlm.nih.gov/pubmed/28178129
http://dx.doi.org/10.1097/MD.0000000000005903

Ejemplares similares